These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention. Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976 [TBL] [Abstract][Full Text] [Related]
7. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ; Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056 [TBL] [Abstract][Full Text] [Related]
8. Intracranial atherosclerotic disease: epidemiology, imaging and treatment. McTaggart RA; Jayaraman MV; Haas RA; Feldmann E Med Health R I; 2009 Dec; 92(12):412-4. PubMed ID: 20066829 [TBL] [Abstract][Full Text] [Related]
9. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease. Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656 [TBL] [Abstract][Full Text] [Related]
10. Management of patients with symptomatic intracranial atherosclerosis. Leung TW; Kwon SU; Wong KS Int J Stroke; 2006 Feb; 1(1):20-5. PubMed ID: 18706064 [TBL] [Abstract][Full Text] [Related]
11. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis. Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet agents and randomized trials. Diener HC Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669 [TBL] [Abstract][Full Text] [Related]
13. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485 [TBL] [Abstract][Full Text] [Related]
14. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316 [TBL] [Abstract][Full Text] [Related]
15. Natural history of symptomatic intracranial arterial stenosis. Kasner SE J Neuroimaging; 2009 Oct; 19 Suppl 1():20S-1S. PubMed ID: 19807853 [TBL] [Abstract][Full Text] [Related]
16. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis. Qureshi AI; Hussein HM; El-Gengaihy A; Abdelmoula M; K Suri MF Neurosurgery; 2008 May; 62(5):1053-60; discussion 1060-2. PubMed ID: 18580803 [TBL] [Abstract][Full Text] [Related]
17. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593 [TBL] [Abstract][Full Text] [Related]
18. Treatment of intracranial arterial stenosis. Taylor RA; Kasner SE Expert Rev Neurother; 2006 Nov; 6(11):1685-94. PubMed ID: 17144782 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Mazighi M; Tanasescu R; Ducrocq X; Vicaut E; Bracard S; Houdart E; Woimant F Neurology; 2006 Apr; 66(8):1187-91. PubMed ID: 16636236 [TBL] [Abstract][Full Text] [Related]